Filter
1712
Filtered Results: 1712
Text search:
Africa
Centres
for
Disease
Control
and
Prevention
Center
for
Disease
Dynamics,
Economics
&
Policy
Featured
Recommendations
167
New Publications
432
Language
Document type
No document type
947
Studies & Reports
346
Guidelines
204
Manuals
99
Strategic & Response Plan
47
Fact sheets
25
Training Material
21
Situation Updates
17
Infographics
3
Resource Platforms
2
Online Courses
1
Countries / Regions
Liberia
67
Ethiopia
65
Africa
59
Global
57
Sierra Leone
52
Kenya
50
Nigeria
40
Rwanda
39
Tanzania
29
Uganda
28
India
27
Zambia
25
Malawi
25
Mozambique
22
Guinea
19
South Africa
19
Senegal
18
Congo, Democratic Republic of
18
Ghana
17
Latin America and the Carribbean
17
Nepal
15
Lesotho
15
Zimbabwe
13
West and Central Africa
13
Asia
13
Burkina Faso
12
Ukraine
12
Middle East and North Africa
12
Western and Central Europe
12
South Sudan
11
Namibia
11
Syria
10
Bangladesh
10
East and Southern Africa
10
Angola
9
Yemen
9
Cambodia
8
Eastern Europe
8
Philippines
7
Botswana
7
Cameroon
6
Eswatini/ Swaziland
6
South–East Asia Region
6
Haiti
5
Pakistan
5
Central African Republic
5
Brazil
5
Myanmar / Burma
5
Russia
5
Somalia
4
Thailand
4
Indonesia
4
Eastern Europe and Central Asia
4
Guinea-Bissau
3
Afghanistan
3
Benin
3
Albania
3
Mali
2
USA
2
Jordan
2
Germany
2
Turkey
2
China
2
Burundi
2
Libya
2
Madagascar
2
Sri Lanka
2
Armenia
2
Vietnam
2
Gabon
2
France
2
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Malaysia
1
Papua New Guinea
1
Argentina
1
North Macedonia
1
Bolivia
1
Greece
1
Mexico
1
Chile
1
Western Pacific Region
1
Venezuela
1
Palestine
1
Italy
1
Southern Africa
1
Canada
1
Tajikistan
1
Qatar
1
Georgia
1
North America
1
Japan
1
Belgium
1
Mauritius
1
United Kingdom
1
Portugal
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
547
Clinical Guidelines
162
Public Health
107
Women & Child Health
82
Key Resources
72
Capacity Building
35
Pharmacy & Technologies
20
Toolboxes
HIV
182
COVID-19
152
TB
117
Mental Health
103
Ebola
95
AMR
88
Rapid Response
71
Planetary Health
67
NTDs
45
Caregiver
42
Disability
33
Global Health Education
33
NCDs
28
Refugee
25
Pharmacy
25
Conflict
24
Health Financing Toolbox
18
Zika
15
Natural Hazards
13
Cholera
12
Polio
6
Specific Hazards
5
Social Ethics
2
ДОПОЛНЕНИЕ
СЛУГИ ТЕСТИРОВАНИЯ НА ВИЧ
ДЕКАБРЬ 2016 г.
2016 data
The report was coordinated by Anastasia Pharris and Annemarie Stengaard.
Report review and production support were provided by Andrew J. Amato-Gauci, Mike Catchpole, Denis Coulombier...
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detecti...
This document provides information and recommendations for action, based on the current available knowledge around monkeypox. It is a first draft which will be updated in light of evolving evidence ...
The World Health Organization was requested by Member States to develop a global priority pathogens list (global PPL) of antibiotic-resistant bacteria to help in prioritizing the research and development (R&D) of new ... effective antibiotic treatments. To date, the selection of pathogens for R&D activities has been largely guided by small and large pharmaceutical companies according to a variety of parameters, such as perceived/unmet medical need, pressure of investors, market size, scientific discovery potential, and availability of specific technologies. Previous PPLs, issued by the Centers for Disease Control and Prevention.
(African Development Bank policy research document 1)
The report examines financing in the battle against malaria, focusing on the role of foreign aid. It analyzes whether or not a disease such as malaria can be controlled or eliminated in... without health aid. It also presents a theoretical model of the economics of malaria and shows how health aid can help avoid the “disease trap.” While calling for increased funding from international sources to fight malaria, it also recommends that African countries step up their own efforts, including on domestic resource mobilization. In 2016, governments of endemic countries contributed 31% of the estimated total of US $ 2.7 billion.
Between 2000 and 2014, malaria control efforts were scaled up and worldwide deaths were cut in half. But declining health aid and deprioritized vertical aid (as for malaria), despite its potentially great efficiency, have led to rising numbers of cases. In 2016, 216 million cases of malaria were reported, up from 211 million in 2015. Africa was home to 90% of all malaria cases and 91% of malaria deaths in 2016. Progress appears to have stalled in the global fight against the disease.
The report examines financing in the battle against malaria, focusing on the role of foreign aid. It analyzes whether or not a disease such as malaria can be controlled or eliminated in
Between 2000 and 2014, malaria control efforts were scaled up and worldwide deaths were cut in half. But declining health aid and deprioritized vertical aid (as for malaria), despite its potentially great efficiency, have led to rising numbers of cases. In 2016, 216 million cases of malaria were reported, up from 211 million in 2015. Africa was home to 90% of all malaria cases and 91% of malaria deaths in 2016. Progress appears to have stalled in the global fight against the disease.
The article outlines the prioritized research agenda for the prevention and control of chronic r...
The Government of the Republic of Zambia has placed priority on ensuring that Zambians are healthy and productive as a catalyst to the attainment of socioeconomic development . The Vision 2030 aims to transform Zambia into a prosperous middle-income...
In 2016, the risk of premature mortality1 from noncommunicable diseases (NCDs) in Ethiopia was 18.3%. The economic costs of NCDs are significant and are due principally to their impact on the non-he...
Infectious disease outbreaks and epidemics are increasing in frequency, scale and impact. Health care facilities can amplify the transmission of em...
The WHO document "Integrating the prevention and control of noncommunicable diseases in HIV/AIDS...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations ... community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons. The guidance also addresses considerations for clinical management such as the use of therapeutics, nutritional support, mental health services, and post-infection follow-up.
The document provides guidance for clinicians, health facility managers, health workers and infection prevention and control practitioners including but not limited to those working in primary care clinics, sexual health clinics, emergency departments, infectious diseases clinics, genitourinary clinics, dermatology clinics, maternity services, paediatrics, obstetrics and gynaecology and acute care facilities that provide care for patients with suspected or confirmed monkeypox
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, ... South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people living with HIV, among whom the most frequent clinical presentation is disseminated histoplasmosis. The symptoms of disseminated histoplasmosis are non-specific and may be indistinguishable from those of other infectious diseases, especially disseminated tuberculosis (TB), thus complicating diagnosis and treatment. Histoplasmosis is one of the most frequent opportunistic infections caused by fungal pathogens among people living with HIV in the Americas and may be responsible for 5–15% of AIDS-related deaths every year in this Region. These guidelines aim to provide recommendations for the diagnosis, treatment, and management of disseminated histoplasmosis in persons living with HIV
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
coun...
